THIAMINE HYDROCHLORIDE

THIAMINE HYDROCHLORIDE was reported 30745 times

THIAMINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GASTRIC ILEUS 23 0.4035
1 ELECTROCARDIOGRAM T WAVE ALTERNANS 12 0.2791
2 ENCEPHALITIS TOXIC 17 0.2152
3 PRESBYACUSIS 49 0.1591
4 FAILURE TO ANASTOMOSE 13 0.1182
5 VAGINAL FLATULENCE 33 0.1089
6 CAPILLARITIS 27 0.0978
7 NONALCOHOLIC FATTY LIVER DISEASE 19 0.0969
8 DECREASED GAIT VELOCITY 15 0.0893
9 NEGLECT OF PERSONAL APPEARANCE 21 0.0864
10 VITAMIN B1 DEFICIENCY 35 0.0820
11 PLEURAL THICKENING 51 0.0746
12 TOTAL LUNG CAPACITY ABNORMAL 24 0.0617
13 STARVATION KETOACIDOSIS 12 0.0594
14 BLOOD MAGNESIUM INCREASED 51 0.0565
15 GAIT SPASTIC 19 0.0554
16 RHEUMATIC FEVER 244 0.0547
17 ALCOHOLIC LIVER DISEASE 18 0.0531
18 PULMONARY VASCULITIS 27 0.0502
19 PLEURAL FIBROSIS 51 0.0500
20 ONYCHOMADESIS 203 0.0483
21 ALCOHOL WITHDRAWAL SYNDROME 40 0.0460
22 MITE ALLERGY 30 0.0458
23 FACET JOINT SYNDROME 149 0.0457
24 SPIROMETRY ABNORMAL 26 0.0435
25 NEEDLE FATIGUE 19 0.0416
26 SARCOPENIA 18 0.0416
27 ONYCHOMYCOSIS 181 0.0412
28 C-REACTIVE PROTEIN ABNORMAL 260 0.0405
29 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 28 0.0382
30 PERIPHERAL VENOUS DISEASE 147 0.0360
31 MYCOTIC ALLERGY 30 0.0351
32 DELIRIUM TREMENS 14 0.0347
33 DISLOCATION OF VERTEBRA 79 0.0346
34 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 68 0.0328
35 CIRRHOSIS ALCOHOLIC 15 0.0328
36 DUST ALLERGY 29 0.0296
37 GASTROSCHISIS 14 0.0294
38 RESPIRATORY TRACT INFECTION BACTERIAL 14 0.0281
39 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 15 0.0267
40 EPIDERMAL NECROSIS 26 0.0267
41 BLEPHAROSPASM 163 0.0259
42 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 183 0.0255
43 PORTAL HYPERTENSIVE GASTROPATHY 14 0.0248
44 PRESSURE OF SPEECH 16 0.0246
45 DELUSION OF GRANDEUR 11 0.0245
46 PEMPHIGUS 299 0.0239
47 BONE CYST 21 0.0224
48 IRON OVERLOAD 24 0.0222
49 RELAPSING-REMITTING MULTIPLE SCLEROSIS 19 0.0220
50 DUODENAL ULCER PERFORATION 163 0.0219
51 FEMALE GENITAL TRACT FISTULA 37 0.0217
52 RHEUMATOID FACTOR POSITIVE 121 0.0209
53 OPHTHALMOPLEGIA 33 0.0209
54 FINGER DEFORMITY 98 0.0202
55 CONJUNCTIVITIS ALLERGIC 29 0.0196
56 NEURITIS 30 0.0194
57 APTYALISM 16 0.0187
58 LIP DRY 169 0.0186
59 BREAST CANCER STAGE III 119 0.0184
60 MUSCLE INJURY 140 0.0169
61 DEAFNESS NEUROSENSORY 55 0.0167
62 LUPUS VULGARIS 21 0.0167
63 BEZOAR 23 0.0167
64 BLOOD FOLATE DECREASED 12 0.0165
65 SYNOVITIS 295 0.0163
66 PRODUCT LABEL CONFUSION 95 0.0163
67 OSMOTIC DEMYELINATION SYNDROME 12 0.0163
68 VITAMIN B COMPLEX DEFICIENCY 12 0.0162
69 FOLLICULITIS 165 0.0157
70 SWOLLEN JOINT COUNT INCREASED 50 0.0157
71 X-RAY ABNORMAL 28 0.0156
72 DEEP VEIN THROMBOSIS POSTOPERATIVE 31 0.0155
73 PERICARDITIS 259 0.0154
74 HELICOBACTER INFECTION 150 0.0146
75 BLOOD UREA DECREASED 18 0.0145
76 GRIP STRENGTH DECREASED 127 0.0144
77 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 29 0.0142
78 HAND DEFORMITY 185 0.0141
79 OSTEOSCLEROSIS 22 0.0140
80 BURSITIS 164 0.0135
81 LIVE BIRTH 112 0.0134
82 EPIGASTRIC DISCOMFORT 52 0.0133
83 CLOSTRIDIUM TEST POSITIVE 29 0.0131
84 NAIL DISORDER 115 0.0131
85 C-REACTIVE PROTEIN 12 0.0129
86 RADICULOPATHY 34 0.0129
87 HYPERCHOLESTEROLAEMIA 121 0.0125
88 COMA SCALE ABNORMAL 36 0.0124
89 TOXIC EPIDERMAL NECROLYSIS 188 0.0124
90 NORMOCHROMIC NORMOCYTIC ANAEMIA 37 0.0123
91 PROCTITIS 34 0.0121
92 WOUND INFECTION 132 0.0120
93 FOETAL MALFORMATION 13 0.0120
94 HYPOGONADISM 12 0.0119
95 DEMENTIA WITH LEWY BODIES 13 0.0117
96 POSTICTAL STATE 12 0.0115
97 CONSCIOUSNESS FLUCTUATING 12 0.0115
98 CEREBELLAR ATAXIA 11 0.0115
99 JOINT RANGE OF MOTION DECREASED 152 0.0113
100 WOUND 305 0.0109
101 RESPIRATORY SYMPTOM 31 0.0109
102 SPINAL DEFORMITY 18 0.0107
103 MONOPARESIS 19 0.0105
104 HEPATIC ENCEPHALOPATHY 97 0.0104
105 BACK INJURY 113 0.0104
106 FORCED EXPIRATORY VOLUME DECREASED 29 0.0102
107 INFUSION SITE REACTION 30 0.0100
108 CHRONIC SINUSITIS 37 0.0098
109 COELIAC DISEASE 96 0.0098
110 OCULOGYRIC CRISIS 20 0.0093
111 PNEUMOCYSTIS JIROVECII INFECTION 11 0.0092
112 MASTICATION DISORDER 28 0.0091
113 GLOSSODYNIA 196 0.0087
114 OESOPHAGEAL VARICES HAEMORRHAGE 19 0.0087
115 IMPAIRED SELF-CARE 18 0.0087
116 ALCOHOLISM 37 0.0086
117 VARICES OESOPHAGEAL 26 0.0086
118 SYSTEMIC LUPUS ERYTHEMATOSUS 297 0.0084
119 TASTE DISORDER 169 0.0083
120 ANION GAP INCREASED 11 0.0082
121 BONE EROSION 29 0.0082
122 OBESITY 130 0.0082
123 HYPOMAGNESAEMIA 110 0.0079
124 PARAINFLUENZAE VIRUS INFECTION 12 0.0079
125 STRABISMUS 23 0.0078
126 CONTRAINDICATED PRODUCT ADMINISTERED 236 0.0078
127 DISCOURAGEMENT 18 0.0077
128 TYPE 2 DIABETES MELLITUS 255 0.0076
129 RETINITIS 13 0.0075
130 NORMAL NEWBORN 40 0.0074
131 EPILEPSY 224 0.0073
132 REGURGITATION 25 0.0073
133 HYPERTONIC BLADDER 21 0.0073
134 VITAMIN B12 DEFICIENCY 29 0.0072
135 C-REACTIVE PROTEIN INCREASED 259 0.0071
136 ALCOHOL ABUSE 19 0.0071
137 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 12 0.0071
138 ALCOHOL POISONING 19 0.0071
139 LIVER INJURY 174 0.0071
140 COMMUNICATION DISORDER 27 0.0071
141 NEUTROPENIC SEPSIS 50 0.0070
142 UPPER GASTROINTESTINAL HAEMORRHAGE 117 0.0069
143 DELIRIUM 241 0.0069
144 ADVERSE REACTION 92 0.0069
145 FIBROMYALGIA 168 0.0069
146 RESPIRATORY TRACT INFECTION VIRAL 16 0.0069
147 IRRITABLE BOWEL SYNDROME 144 0.0067
148 BREAST CANCER STAGE II 55 0.0066
149 AORTIC ARTERIOSCLEROSIS 17 0.0066
150 HEPATORENAL SYNDROME 11 0.0065
151 CHOREA 11 0.0064
152 PSORIATIC ARTHROPATHY 258 0.0063
153 HYPERAMMONAEMIC ENCEPHALOPATHY 11 0.0063
154 LOWER RESPIRATORY TRACT INFECTION 281 0.0062
155 HEPATIC CIRRHOSIS 115 0.0061
156 CATATONIA 32 0.0061
157 FOETAL GROWTH RESTRICTION 37 0.0061
158 ATAXIA 72 0.0061
159 MALNUTRITION 67 0.0060
160 HYPERPARATHYROIDISM SECONDARY 15 0.0060
161 ELECTROCARDIOGRAM QT PROLONGED 213 0.0059
162 GAIT INABILITY 197 0.0059
163 ARTERIOSCLEROSIS CORONARY ARTERY 39 0.0059
164 ODYNOPHAGIA 35 0.0059
165 OSTEOARTHRITIS 242 0.0057
166 PULMONARY ALVEOLAR HAEMORRHAGE 32 0.0057
167 HYPONATRAEMIA 320 0.0057
168 PNEUMONIA CYTOMEGALOVIRAL 11 0.0057
169 NEUROLOGICAL SYMPTOM 32 0.0056
170 LIVER FUNCTION TEST INCREASED 119 0.0055
171 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 95 0.0055
172 TOXIC ENCEPHALOPATHY 28 0.0055
173 CEREBELLAR SYNDROME 12 0.0055
174 EXOSTOSIS 50 0.0055
175 PULMONARY FIBROSIS 105 0.0055
176 COMPARTMENT SYNDROME 14 0.0054
177 THERAPEUTIC PRODUCT EFFECT DECREASED 240 0.0054
178 NYSTAGMUS 28 0.0053
179 ALCOHOL USE 19 0.0051
180 POLYDIPSIA 20 0.0051
181 CACHEXIA 26 0.0050
182 NIGHT SWEATS 162 0.0050
183 INFUSION RELATED REACTION 333 0.0050
184 HYPERNATRAEMIA 25 0.0050
185 DRUG-INDUCED LIVER INJURY 157 0.0050
186 SEROTONIN SYNDROME 96 0.0050
187 BLOOD MAGNESIUM DECREASED 43 0.0050
188 NEPHROGENIC ANAEMIA 23 0.0050
189 HEPATITIS 127 0.0050
190 PUSTULAR PSORIASIS 17 0.0049
191 SLOW SPEECH 12 0.0049
192 PRESCRIBED OVERDOSE 93 0.0048
193 ENCEPHALOPATHY 116 0.0047
194 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 18 0.0047
195 DUODENAL ULCER 33 0.0047
196 CYST 58 0.0047
197 BLOOD ALBUMIN DECREASED 37 0.0047
198 SLEEP DISORDER 329 0.0047
199 UROSEPSIS 43 0.0047
200 SKIN ABRASION 22 0.0047
201 LUPUS-LIKE SYNDROME 42 0.0046
202 EOSINOPHIL COUNT DECREASED 11 0.0046
203 ANTIPSYCHOTIC DRUG LEVEL INCREASED 13 0.0046
204 PNEUMONIA ASPIRATION 114 0.0046
205 MUSCLE RIGIDITY 54 0.0045
206 OESOPHAGITIS 49 0.0045
207 OSTEOPENIA 68 0.0045
208 NECK PAIN 250 0.0045
209 IMPAIRED HEALING 146 0.0044
210 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 45 0.0044
211 RASH VESICULAR 21 0.0043
212 CARDIAC DYSFUNCTION 16 0.0043
213 HEAD DISCOMFORT 76 0.0043
214 LOWER LIMB FRACTURE 82 0.0043
215 ARTHROPATHY 237 0.0043
216 OROPHARYNGEAL DISCOMFORT 38 0.0042
217 LEFT VENTRICULAR HYPERTROPHY 18 0.0042
218 PRESCRIBED UNDERDOSE 83 0.0042
219 CONFUSIONAL STATE 672 0.0042
220 ARTERIOSCLEROSIS 39 0.0041
221 FEMORAL NECK FRACTURE 21 0.0041
222 LUNG DISORDER 200 0.0041
223 WHEEZING 241 0.0041
224 INFLAMMATORY MARKER INCREASED 20 0.0040
225 BLOOD POTASSIUM INCREASED 65 0.0040
226 HEART DISEASE CONGENITAL 14 0.0040
227 HYPOTHERMIA 40 0.0039
228 HAEMORRHAGIC DIATHESIS 14 0.0039
229 AMMONIA INCREASED 20 0.0039
230 DRUG TOLERANCE DECREASED 11 0.0039
231 PORTAL HYPERTENSION 12 0.0039
232 NEUROLEPTIC MALIGNANT SYNDROME 46 0.0039
233 BLOOD CREATININE DECREASED 12 0.0038
234 APLASTIC ANAEMIA 20 0.0038
235 TREATMENT FAILURE 316 0.0038
236 ASCITES 111 0.0038
237 GASTROOESOPHAGEAL REFLUX DISEASE 303 0.0038
238 HAEMATEMESIS 95 0.0037
239 HYPERREFLEXIA 13 0.0037
240 ILL-DEFINED DISORDER 225 0.0037
241 INFLAMMATION 189 0.0037
242 FAILURE TO THRIVE 19 0.0037
243 METABOLIC ACIDOSIS 117 0.0037
244 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 260 0.0037
245 HYPOPHOSPHATAEMIA 27 0.0036
246 PARTIAL SEIZURES 19 0.0036
247 RED BLOOD CELL SEDIMENTATION RATE INCREASED 40 0.0036
248 HYPERAMMONAEMIA 18 0.0036
249 FLUID INTAKE REDUCED 18 0.0036
250 OBSTRUCTIVE AIRWAYS DISORDER 40 0.0036
251 MYOSITIS 32 0.0036
252 DIASTOLIC DYSFUNCTION 11 0.0036
253 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 23 0.0035
254 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 60 0.0035
255 BRAIN INJURY 35 0.0035
256 HEPATIC NECROSIS 13 0.0034
257 INTESTINAL ISCHAEMIA 19 0.0034
258 INJECTION SITE REACTION 237 0.0034
259 BLOOD CHOLESTEROL INCREASED 160 0.0034
260 HYPOVOLAEMIA 20 0.0034
261 TROPONIN INCREASED 26 0.0034
262 MUSCULOSKELETAL PAIN 179 0.0034
263 MOBILITY DECREASED 245 0.0034
264 BLOOD PROLACTIN INCREASED 16 0.0034
265 HEPATIC ENZYME INCREASED 231 0.0034
266 BACK DISORDER 55 0.0034
267 VAGINAL DISCHARGE 34 0.0034
268 ACUTE KIDNEY INJURY 513 0.0033
269 DELUSION 52 0.0033
270 RESPIRATORY DEPRESSION 41 0.0033
271 ORAL CANDIDIASIS 44 0.0033
272 NEUTROPHIL COUNT INCREASED 34 0.0033
273 DRUG INTOLERANCE 320 0.0033
274 ATELECTASIS 32 0.0033
275 JAUNDICE 89 0.0033
276 TUMOUR LYSIS SYNDROME 29 0.0033
277 PNEUMONIA FUNGAL 13 0.0033
278 SCHIZOPHRENIA 40 0.0033
279 ELECTROLYTE IMBALANCE 38 0.0033
280 PSEUDOMONAS INFECTION 28 0.0033
281 SWELLING 305 0.0033
282 ULCER HAEMORRHAGE 22 0.0032
283 OEDEMA 175 0.0032
284 FULL BLOOD COUNT ABNORMAL 34 0.0032
285 STOMATITIS 194 0.0032
286 DIZZINESS POSTURAL 31 0.0032
287 INJURY 224 0.0032
288 GENERAL PHYSICAL HEALTH DETERIORATION 367 0.0032
289 DERMATITIS EXFOLIATIVE GENERALISED 11 0.0032
290 SPUTUM DISCOLOURED 30 0.0032
291 LEFT VENTRICULAR DYSFUNCTION 21 0.0031
292 FIBRIN D DIMER INCREASED 11 0.0031
293 BLISTER 173 0.0031
294 MENTAL STATUS CHANGES 85 0.0031
295 HYPOXIA 107 0.0030
296 HYPERVOLAEMIA 15 0.0030
297 BLOOD SODIUM DECREASED 57 0.0030
298 RHEUMATOID ARTHRITIS 343 0.0030
299 ABDOMINAL TENDERNESS 15 0.0030
300 CLOSTRIDIUM DIFFICILE COLITIS 32 0.0030
301 MACULAR DEGENERATION 36 0.0030
302 RESPIRATORY FAILURE 219 0.0030
303 BRADYCARDIA 159 0.0030
304 NODULE 39 0.0030
305 SPINAL PAIN 35 0.0030
306 URINE OUTPUT DECREASED 26 0.0030
307 SOCIAL PROBLEM 12 0.0029
308 MULTIPLE ORGAN DYSFUNCTION SYNDROME 82 0.0029
309 HYPOPHAGIA 74 0.0029
310 MYOCARDITIS 33 0.0029
311 ACIDOSIS 22 0.0029
312 BACTERAEMIA 34 0.0029
313 MYOCLONUS 34 0.0028
314 ATRIOVENTRICULAR BLOCK COMPLETE 19 0.0028
315 LIVER FUNCTION TEST ABNORMAL 82 0.0028
316 BLOOD CHOLESTEROL ABNORMAL 13 0.0028
317 ACUTE RESPIRATORY FAILURE 54 0.0028
318 BEHAVIOUR DISORDER 15 0.0028
319 HEPATITIS ACUTE 18 0.0028
320 STAPHYLOCOCCAL BACTERAEMIA 12 0.0028
321 DYSPEPSIA 271 0.0028
322 HYPOKALAEMIA 127 0.0027
323 HYPOCALCAEMIA 52 0.0027
324 WALKING AID USER 18 0.0027
325 IMMUNOSUPPRESSION 24 0.0027
326 UNRESPONSIVE TO STIMULI 70 0.0027
327 HYPERKALAEMIA 95 0.0027
328 LEUKOCYTOSIS 49 0.0027
329 CARDIOMYOPATHY 40 0.0027
330 LOWER GASTROINTESTINAL HAEMORRHAGE 20 0.0027
331 CIRCULATORY COLLAPSE 46 0.0027
332 DRY MOUTH 219 0.0027
333 POLYURIA 22 0.0027
334 MIGRAINE 256 0.0027
335 ELECTROCARDIOGRAM ABNORMAL 21 0.0027
336 SINUS TACHYCARDIA 38 0.0027
337 DEFORMITY 25 0.0027
338 AUTOIMMUNE DISORDER 26 0.0027
339 INTERNATIONAL NORMALISED RATIO INCREASED 76 0.0027
340 SKIN LESION 73 0.0027
341 SUSPECTED OFF LABEL USE 12 0.0027
342 HEPATIC FAILURE 80 0.0027
343 RENAL TUBULAR NECROSIS 26 0.0026
344 VASCULAR DEVICE INFECTION 12 0.0026
345 HYPERBILIRUBINAEMIA 27 0.0026
346 MUSCLE ATROPHY 33 0.0026
347 SOCIAL AVOIDANT BEHAVIOUR 15 0.0026
348 MELAENA 57 0.0026
349 HYPERTRANSAMINASAEMIA 18 0.0026
350 GENERALISED OEDEMA 32 0.0026
351 DECUBITUS ULCER 21 0.0026
352 HEPATIC STEATOSIS 48 0.0026
353 PERIPHERAL SENSORY NEUROPATHY 15 0.0026
354 PARAESTHESIA ORAL 37 0.0026
355 PARKINSONISM 25 0.0026
356 DYSLIPIDAEMIA 13 0.0026
357 HAEMOPTYSIS 71 0.0025
358 FAECES DISCOLOURED 55 0.0025
359 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 19 0.0025
360 DYSTONIA 49 0.0025
361 CARDIOMEGALY 31 0.0025
362 HEPATIC CYTOLYSIS 32 0.0025
363 DYSPHEMIA 11 0.0025
364 TUBULOINTERSTITIAL NEPHRITIS 47 0.0025
365 PERIORBITAL OEDEMA 13 0.0025
366 TUMOUR MARKER INCREASED 12 0.0025
367 AKATHISIA 34 0.0025
368 IRON DEFICIENCY ANAEMIA 23 0.0025
369 VASCULITIS 29 0.0025
370 INFUSION SITE PAIN 32 0.0025
371 NOCTURIA 30 0.0025
372 SERUM FERRITIN INCREASED 13 0.0025
373 BLOOD POTASSIUM DECREASED 74 0.0025
374 JOINT SWELLING 297 0.0025
375 JOINT DISLOCATION 26 0.0025
376 DISCOMFORT 150 0.0025
377 HALLUCINATION, AUDITORY 39 0.0025
378 RECTAL HAEMORRHAGE 105 0.0024
379 DYSARTHRIA 92 0.0024
380 HAEMATOMA 63 0.0024
381 TORSADE DE POINTES 19 0.0024
382 MUSCULOSKELETAL STIFFNESS 212 0.0024
383 EXPOSURE DURING PREGNANCY 150 0.0024
384 GASTROINTESTINAL DISORDER 216 0.0024
385 BLOOD CALCIUM DECREASED 27 0.0024
386 MATERNAL EXPOSURE DURING PREGNANCY 213 0.0024
387 PEMPHIGOID 18 0.0024
388 MICTURITION URGENCY 27 0.0024
389 ECCHYMOSIS 16 0.0023
390 SCIATICA 37 0.0023
391 ACUTE PULMONARY OEDEMA 13 0.0023
392 HYPOALBUMINAEMIA 18 0.0023
393 MENTAL IMPAIRMENT 56 0.0023
394 COMA 110 0.0023
395 END STAGE RENAL DISEASE 42 0.0023
396 VENTRICULAR TACHYCARDIA 38 0.0023
397 SEDATION 60 0.0023
398 ASPIRATION 25 0.0023
399 EMPHYSEMA 23 0.0023
400 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 109 0.0023
401 GENERAL SYMPTOM 17 0.0023
402 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 118 0.0023
403 FLUID RETENTION 115 0.0023
404 STATUS EPILEPTICUS 25 0.0022
405 SHOCK HAEMORRHAGIC 18 0.0022
406 SEPTIC SHOCK 96 0.0022
407 AGITATION 162 0.0022
408 MYOPATHY 19 0.0022
409 CORONARY ARTERY STENOSIS 11 0.0022
410 LIVER DISORDER 96 0.0022
411 CEREBRAL DISORDER 16 0.0022
412 HIATUS HERNIA 28 0.0022
413 HYPOTHYROIDISM 69 0.0022
414 CLOSTRIDIUM DIFFICILE INFECTION 47 0.0022
415 LYMPHOCYTE COUNT DECREASED 38 0.0021
416 FREQUENT BOWEL MOVEMENTS 58 0.0021
417 MUSCULAR WEAKNESS 244 0.0021
418 INTENTIONAL PRODUCT USE ISSUE 188 0.0021
419 RENAL CYST 17 0.0021
420 BLOOD CREATININE INCREASED 139 0.0021
421 HAEMOLYTIC ANAEMIA 19 0.0021
422 MUSCLE SPASTICITY 26 0.0021
423 VITAMIN D DECREASED 18 0.0021
424 COAGULOPATHY 35 0.0021
425 MATERNAL DRUGS AFFECTING FOETUS 16 0.0021
426 BREAST MASS 14 0.0021
427 HAEMOGLOBIN DECREASED 213 0.0021
428 CARDIAC ARREST 171 0.0021
429 CONGENITAL ANOMALY 16 0.0021
430 RALES 12 0.0021
431 INFUSION SITE SWELLING 13 0.0021
432 MUCOSAL INFLAMMATION 54 0.0021
433 HYPOAESTHESIA 308 0.0021
434 APATHY 30 0.0021
435 AMNESIA 133 0.0020
436 RIB FRACTURE 42 0.0020
437 LETHARGY 117 0.0020
438 WHITE BLOOD CELL COUNT INCREASED 78 0.0020
439 ROAD TRAFFIC ACCIDENT 85 0.0020
440 SUBDURAL HAEMATOMA 29 0.0020
441 ABDOMINAL DISTENSION 211 0.0020
442 INFUSION SITE ERYTHEMA 17 0.0020
443 BLOOD CREATINE PHOSPHOKINASE INCREASED 58 0.0020
444 SKIN ULCER 52 0.0020
445 ORTHOSTATIC HYPOTENSION 35 0.0020
446 HYPERLIPIDAEMIA 24 0.0020
447 PERIPHERAL SWELLING 309 0.0020
448 TRANSFUSION 21 0.0020
449 HYPERGLYCAEMIA 73 0.0020
450 HYPOTENSION 401 0.0020
451 OBSESSIVE-COMPULSIVE DISORDER 16 0.0020
452 DERMATITIS ALLERGIC 25 0.0020
453 SPLENOMEGALY 23 0.0020
454 PANCREATITIS ACUTE 44 0.0020
455 CARDIAC FAILURE ACUTE 13 0.0019
456 GOUT 35 0.0019
457 DECREASED ACTIVITY 21 0.0019
458 PERICARDIAL EFFUSION 45 0.0019
459 HALLUCINATION, VISUAL 41 0.0019
460 CHOLECYSTITIS ACUTE 11 0.0019
461 DYSPNOEA EXERTIONAL 73 0.0019
462 NEUTROPHILIA 11 0.0019
463 CARPAL TUNNEL SYNDROME 27 0.0019
464 DRUG INTERACTION 305 0.0019
465 HAEMORRHAGIC STROKE 15 0.0019
466 CONDITION AGGRAVATED 583 0.0019
467 MAJOR DEPRESSION 14 0.0019
468 RESPIRATORY RATE INCREASED 17 0.0019
469 LACTIC ACIDOSIS 62 0.0019
470 MEMORY IMPAIRMENT 262 0.0019
471 SEPSIS 212 0.0019
472 COLITIS 72 0.0019
473 GASTRIC ULCER 36 0.0019
474 PARAESTHESIA 298 0.0019
475 ANAL INCONTINENCE 17 0.0019
476 STEVENS-JOHNSON SYNDROME 42 0.0019
477 NEUROTOXICITY 33 0.0019
478 CARDIOGENIC SHOCK 27 0.0019
479 HAEMOGLOBIN ABNORMAL 12 0.0019
480 FLUID OVERLOAD 27 0.0019
481 BLOOD ALKALINE PHOSPHATASE INCREASED 46 0.0019
482 EAR PAIN 36 0.0018
483 DIABETIC KETOACIDOSIS 44 0.0018
484 MANIA 30 0.0018
485 SPINAL OSTEOARTHRITIS 16 0.0018
486 LIGAMENT SPRAIN 18 0.0018
487 DRUG LEVEL INCREASED 30 0.0018
488 ATRIOVENTRICULAR BLOCK 14 0.0018
489 RESPIRATORY DISORDER 54 0.0018
490 MOUTH ULCERATION 38 0.0018
491 TACHYCARDIA 157 0.0018
492 SEASONAL ALLERGY 25 0.0018
493 ATRIAL FLUTTER 14 0.0018
494 INCORRECT PRODUCT ADMINISTRATION DURATION 38 0.0018
495 RASH MACULO-PAPULAR 39 0.0018
496 GENERALISED TONIC-CLONIC SEIZURE 29 0.0018
497 HALLUCINATION 132 0.0017
498 TRANSPLANT REJECTION 14 0.0017
499 CENTRAL NERVOUS SYSTEM LESION 24 0.0017
500 MIOSIS 14 0.0017
501 FRUSTRATION TOLERANCE DECREASED 14 0.0017
502 LARGE INTESTINE POLYP 12 0.0017
503 RESPIRATORY TRACT INFECTION 45 0.0017
504 RHABDOMYOLYSIS 72 0.0017
505 HOSPICE CARE 17 0.0017
506 PRODUCT USE ISSUE 323 0.0017
507 GASTROINTESTINAL HAEMORRHAGE 143 0.0017
508 URINARY RETENTION 57 0.0017
509 INCONTINENCE 18 0.0017
510 HYPERTHERMIA 13 0.0017
511 LUNG INFILTRATION 15 0.0017
512 PROCEDURAL PAIN 47 0.0017
513 PLATELET COUNT INCREASED 22 0.0017
514 HAEMATOCHEZIA 93 0.0017
515 TREATMENT NONCOMPLIANCE 92 0.0017
516 EOSINOPHIL COUNT INCREASED 14 0.0017
517 ALANINE AMINOTRANSFERASE INCREASED 103 0.0017
518 SLEEP APNOEA SYNDROME 32 0.0017
519 SUPRAVENTRICULAR TACHYCARDIA 16 0.0017
520 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 43 0.0017
521 DYSGRAPHIA 11 0.0017
522 GAMMA-GLUTAMYLTRANSFERASE INCREASED 37 0.0017
523 RESPIRATORY DISTRESS 46 0.0017
524 FALL 554 0.0017
525 EOSINOPHILIA 29 0.0017
526 SEIZURE 191 0.0017
527 ADRENAL INSUFFICIENCY 20 0.0016
528 PRODUCT USE IN UNAPPROVED INDICATION 408 0.0016
529 MOUTH HAEMORRHAGE 12 0.0016
530 OEDEMA PERIPHERAL 199 0.0016
531 BLOOD BILIRUBIN INCREASED 44 0.0016
532 ANGIOEDEMA 72 0.0016
533 GLOMERULAR FILTRATION RATE DECREASED 20 0.0016
534 FEEDING DISORDER 33 0.0016
535 BODY TEMPERATURE DECREASED 16 0.0016
536 RHINITIS 13 0.0016
537 INFECTION 233 0.0016
538 COGNITIVE DISORDER 75 0.0016
539 DEPRESSED LEVEL OF CONSCIOUSNESS 63 0.0016
540 THROMBOCYTOPENIA 178 0.0016
541 HYPERSENSITIVITY 295 0.0016
542 URINARY INCONTINENCE 47 0.0016
543 ECONOMIC PROBLEM 24 0.0016
544 RENAL IMPAIRMENT 133 0.0016
545 ESCHERICHIA INFECTION 13 0.0016
546 PRODUCTIVE COUGH 75 0.0016
547 SUBARACHNOID HAEMORRHAGE 16 0.0016
548 ABDOMINAL PAIN UPPER 323 0.0016
549 HIP ARTHROPLASTY 24 0.0016
550 CYTOMEGALOVIRUS INFECTION 26 0.0016
551 EUPHORIC MOOD 16 0.0016
552 THINKING ABNORMAL 29 0.0016
553 RENAL FAILURE ACUTE 66 0.0016
554 ERUCTATION 30 0.0015
555 EATING DISORDER 33 0.0015
556 PULMONARY HAEMORRHAGE 12 0.0015
557 FOOT DEFORMITY 17 0.0015
558 POOR QUALITY SLEEP 33 0.0015
559 VENTRICULAR FIBRILLATION 17 0.0015
560 PRODUCT ADMINISTRATION INTERRUPTED 12 0.0015
561 NEUROPATHY PERIPHERAL 145 0.0015
562 DRY EYE 76 0.0015
563 FEBRILE NEUTROPENIA 101 0.0015
564 PANCYTOPENIA 85 0.0015
565 UNDERDOSE 111 0.0015
566 DYSPHAGIA 144 0.0015
567 GRAND MAL CONVULSION 14 0.0015
568 PULMONARY EMBOLISM 144 0.0015
569 TRICUSPID VALVE INCOMPETENCE 12 0.0015
570 DYSSTASIA 44 0.0015
571 CONTUSION 145 0.0015
572 POLYNEUROPATHY 18 0.0015
573 DECREASED APPETITE 349 0.0015
574 DIARRHOEA HAEMORRHAGIC 14 0.0015
575 ABDOMINAL PAIN 347 0.0015
576 THERAPY NON-RESPONDER 67 0.0015
577 BREAST CANCER METASTATIC 16 0.0015
578 PSYCHOTIC DISORDER 44 0.0015
579 PULMONARY HYPERTENSION 31 0.0015
580 PNEUMONIA 481 0.0015
581 ABDOMINAL DISCOMFORT 249 0.0015
582 MYDRIASIS 19 0.0015
583 RASH PAPULAR 33 0.0015
584 HAEMORRHAGE INTRACRANIAL 22 0.0015
585 PURPURA 13 0.0015
586 ACUTE HEPATIC FAILURE 20 0.0015
587 PREMATURE BABY 44 0.0015
588 AGGRESSION 73 0.0015
589 JOINT STIFFNESS 38 0.0014
590 DENTAL CARIES 16 0.0014
591 HYPOGLYCAEMIA 70 0.0014
592 DYSPNOEA 815 0.0014
593 PATHOGEN RESISTANCE 13 0.0014
594 TOXICITY TO VARIOUS AGENTS 239 0.0014
595 REBOUND EFFECT 16 0.0014
596 ACUTE RESPIRATORY DISTRESS SYNDROME 25 0.0014
597 DISORIENTATION 56 0.0014
598 HAEMATOCRIT DECREASED 28 0.0014
599 EXTRAPYRAMIDAL DISORDER 35 0.0014
600 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
601 DEHYDRATION 187 0.0014
602 ALOPECIA 275 0.0014
603 TACHYPNOEA 19 0.0014
604 IMPAIRED GASTRIC EMPTYING 19 0.0014
605 WEIGHT INCREASED 312 0.0014
606 CELLULITIS 70 0.0014
607 PERITONITIS BACTERIAL 14 0.0014
608 ATRIAL FIBRILLATION 134 0.0014
609 FRACTURE 26 0.0014
610 INSURANCE ISSUE 21 0.0014
611 ANAEMIA 261 0.0014
612 DEPRESSED MOOD 72 0.0014
613 HEMIPARESIS 23 0.0014
614 ASTHENIA 508 0.0013
615 HYPERTENSION 286 0.0013
616 TARDIVE DYSKINESIA 38 0.0013
617 MALAISE 585 0.0013
618 HAEMORRHOIDS 26 0.0013
619 PLATELET COUNT DECREASED 142 0.0013
620 GASTRITIS 35 0.0013
621 HEPATITIS C 16 0.0013
622 DECREASED IMMUNE RESPONSIVENESS 13 0.0013
623 PNEUMOTHORAX 21 0.0013
624 RESTLESS LEGS SYNDROME 24 0.0013
625 BALANCE DISORDER 114 0.0013
626 MYOCARDIAL ISCHAEMIA 15 0.0013
627 PAIN IN EXTREMITY 388 0.0013
628 JOINT INJURY 28 0.0013
629 INABILITY TO AFFORD MEDICATION 13 0.0013
630 MUSCLE SPASMS 239 0.0013
631 VOMITING 611 0.0013
632 SALIVARY HYPERSECRETION 13 0.0013
633 PRODUCT DISTRIBUTION ISSUE 12 0.0013
634 ACUTE MYOCARDIAL INFARCTION 38 0.0013
635 ERECTILE DYSFUNCTION 33 0.0013
636 PLEURAL EFFUSION 78 0.0013
637 RENAL FAILURE 170 0.0013
638 CHRONIC KIDNEY DISEASE 97 0.0013
639 EYE PAIN 72 0.0013
640 PHOTOPHOBIA 24 0.0013
641 PULMONARY MASS 19 0.0013
642 STAPHYLOCOCCAL INFECTION 42 0.0013
643 COVID-19 PNEUMONIA 15 0.0013
644 OSTEOMYELITIS 23 0.0013
645 OXYGEN SATURATION DECREASED 71 0.0013
646 RESPIRATORY SYNCYTIAL VIRUS INFECTION 11 0.0013
647 RESPIRATORY TRACT CONGESTION 20 0.0013
648 BLOOD UREA INCREASED 21 0.0013
649 COLITIS ULCERATIVE 56 0.0013
650 PULMONARY OEDEMA 56 0.0012
651 INTESTINAL PERFORATION 14 0.0012
652 MOVEMENT DISORDER 40 0.0012
653 SWELLING FACE 81 0.0012
654 PULMONARY ARTERIAL HYPERTENSION 18 0.0012
655 EAR INFECTION 33 0.0012
656 MITRAL VALVE INCOMPETENCE 14 0.0012
657 VITAMIN D DEFICIENCY 12 0.0012
658 DEPRESSION 278 0.0012
659 MENTAL DISORDER 53 0.0012
660 DEMENTIA 34 0.0012
661 OSTEOPOROSIS 50 0.0012
662 MULTI-ORGAN FAILURE 21 0.0012
663 DISABILITY 24 0.0012
664 PANCREATITIS 64 0.0012
665 DISSEMINATED INTRAVASCULAR COAGULATION 17 0.0012
666 NEUTROPHIL COUNT DECREASED 49 0.0012
667 PYREXIA 415 0.0012
668 POST PROCEDURAL COMPLICATION 23 0.0012
669 BIPOLAR DISORDER 13 0.0012
670 CARDIO-RESPIRATORY ARREST 50 0.0012
671 PAIN 731 0.0012
672 CANDIDA INFECTION 20 0.0012
673 DIZZINESS 589 0.0012
674 OVERDOSE 254 0.0012
675 BODY TEMPERATURE INCREASED 24 0.0012
676 URTICARIA 197 0.0012
677 PNEUMONITIS 32 0.0012
678 SHOCK 27 0.0012
679 DIARRHOEA 751 0.0012
680 EPISTAXIS 87 0.0012
681 TENDONITIS 18 0.0012
682 PARANOIA 20 0.0012
683 INSOMNIA 308 0.0012
684 NIGHTMARE 40 0.0012
685 VENTRICULAR EXTRASYSTOLES 12 0.0012
686 OFF LABEL USE 1009 0.0012
687 TENDERNESS 12 0.0012
688 PETECHIAE 12 0.0011
689 PSYCHOMOTOR HYPERACTIVITY 19 0.0011
690 MASS 16 0.0011
691 ANHEDONIA 30 0.0011
692 INTENTIONAL OVERDOSE 73 0.0011
693 SMALL INTESTINAL OBSTRUCTION 14 0.0011
694 URINARY TRACT INFECTION 194 0.0011
695 SUDDEN DEATH 12 0.0011
696 HYPERCALCAEMIA 14 0.0011
697 ULCER 18 0.0011
698 WEIGHT DECREASED 315 0.0011
699 POLLAKIURIA 47 0.0011
700 TREMOR 187 0.0011
701 SOMNOLENCE 226 0.0011
702 INTENTIONAL DOSE OMISSION 32 0.0011
703 SUICIDE ATTEMPT 68 0.0011
704 FOETAL EXPOSURE DURING PREGNANCY 91 0.0011
705 ARRHYTHMIA 53 0.0011
706 SUICIDAL IDEATION 102 0.0011
707 HOSPITALISATION 171 0.0011
708 RASH 485 0.0011
709 SYNCOPE 111 0.0011
710 RASH ERYTHEMATOUS 53 0.0011
711 ALTERED STATE OF CONSCIOUSNESS 24 0.0011
712 UVEITIS 15 0.0011
713 CYTOKINE RELEASE SYNDROME 22 0.0011
714 PNEUMOCYSTIS JIROVECII PNEUMONIA 11 0.0011
715 ACCIDENTAL OVERDOSE 40 0.0011
716 ASPARTATE AMINOTRANSFERASE INCREASED 58 0.0011
717 BRAIN FOG 17 0.0011
718 NAUSEA 857 0.0011
719 ARTHRALGIA 450 0.0011
720 CHEST PAIN 200 0.0011
721 BLOOD PRESSURE SYSTOLIC INCREASED 21 0.0011
722 COORDINATION ABNORMAL 15 0.0011
723 ANXIETY 306 0.0011
724 BACTERIAL INFECTION 20 0.0011
725 OCULAR DISCOMFORT 12 0.0011
726 TRANSIENT ISCHAEMIC ATTACK 36 0.0011
727 DEEP VEIN THROMBOSIS 69 0.0011
728 DIALYSIS 15 0.0011
729 MUSCLE TWITCHING 24 0.0010
730 FEAR 28 0.0010
731 EJECTION FRACTION DECREASED 16 0.0010
732 BRAIN OEDEMA 13 0.0010
733 PALLOR 28 0.0010
734 WITHDRAWAL SYNDROME 43 0.0010
735 CEREBRAL INFARCTION 25 0.0010
736 AGRANULOCYTOSIS 19 0.0010
737 HEAD INJURY 32 0.0010
738 ISCHAEMIC STROKE 18 0.0010
739 MEDICATION ERROR 56 0.0010
740 CHOLECYSTITIS 12 0.0010
741 HUNGER 14 0.0010
742 CYSTITIS 32 0.0010
743 NASOPHARYNGITIS 184 0.0010
744 GASTROENTERITIS VIRAL 18 0.0010
745 SPEECH DISORDER 52 0.0010
746 BEDRIDDEN 13 0.0010
747 GAIT DISTURBANCE 189 0.0010
748 NEPHROPATHY TOXIC 11 0.0010
749 CONSTIPATION 213 0.0010
750 CHOLELITHIASIS 32 0.0010
751 LOSS OF CONSCIOUSNESS 125 0.0010
752 ABNORMAL WEIGHT GAIN 12 0.0010
753 COLD SWEAT 17 0.0010
754 HYPOKINESIA 14 0.0010
755 RASH PRURITIC 52 0.0010
756 CARDIAC FAILURE CONGESTIVE 77 0.0010
757 DERMATITIS 20 0.0010
758 PRODUCT QUALITY ISSUE 129 0.0009
759 FACE OEDEMA 16 0.0009
760 BACK PAIN 220 0.0009
761 RESPIRATORY ARREST 26 0.0009
762 PREMATURE DELIVERY 15 0.0009
763 CATARACT 56 0.0009
764 IMMUNODEFICIENCY 14 0.0009
765 CHOLESTASIS 18 0.0009
766 UPPER RESPIRATORY TRACT INFECTION 43 0.0009
767 APHASIA 28 0.0009
768 DISTURBANCE IN ATTENTION 50 0.0009
769 CONVULSION 53 0.0009
770 BLOOD TEST ABNORMAL 13 0.0009
771 CEREBRAL HAEMORRHAGE 33 0.0009
772 THROMBOSIS 74 0.0009
773 LOCAL SWELLING 16 0.0009
774 RENAL INJURY 27 0.0009
775 SARS-COV-2 TEST POSITIVE 12 0.0009
776 FATIGUE 706 0.0009
777 BLOOD TRIGLYCERIDES INCREASED 16 0.0009
778 PRESYNCOPE 22 0.0009
779 MUSCULOSKELETAL CHEST PAIN 14 0.0009
780 DRUG ERUPTION 16 0.0009
781 ASTHMA 102 0.0009
782 COUGH 253 0.0009
783 SINUSITIS 92 0.0009
784 TINNITUS 41 0.0009
785 INTENTIONAL SELF-INJURY 18 0.0009
786 CYANOSIS 14 0.0009
787 SINUS CONGESTION 12 0.0009
788 PHARYNGITIS 11 0.0009
789 DYSKINESIA 36 0.0009
790 BLOOD LACTATE DEHYDROGENASE INCREASED 14 0.0009
791 HEADACHE 551 0.0009
792 PRODUCT AVAILABILITY ISSUE 20 0.0009
793 RED BLOOD CELL COUNT DECREASED 25 0.0009
794 NEUTROPENIA 118 0.0009
795 EYE SWELLING 32 0.0009
796 RASH MACULAR 30 0.0009
797 ADVERSE EVENT 79 0.0009
798 TRANSAMINASES INCREASED 19 0.0009
799 SKIN REACTION 12 0.0009
800 PANIC ATTACK 31 0.0008
801 LABORATORY TEST ABNORMAL 25 0.0008
802 CARDIAC FAILURE 68 0.0008
803 FULL BLOOD COUNT DECREASED 17 0.0008
804 COVID-19 148 0.0008
805 ANKLE FRACTURE 13 0.0008
806 FEMUR FRACTURE 26 0.0008
807 IMMUNE SYSTEM DISORDER 11 0.0008
808 SWOLLEN TONGUE 26 0.0008
809 HYPERTHYROIDISM 12 0.0008
810 THERAPY INTERRUPTED 59 0.0008
811 PRODUCT USE COMPLAINT 13 0.0008
812 HYPERHIDROSIS 106 0.0008
813 GASTROENTERITIS 12 0.0008
814 ECZEMA 43 0.0008
815 FEELING HOT 50 0.0008
816 KIDNEY INFECTION 16 0.0008
817 PAIN IN JAW 23 0.0008
818 SINUS DISORDER 16 0.0008
819 ABNORMAL BEHAVIOUR 32 0.0008
820 ORAL PAIN 18 0.0008
821 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 44 0.0008
822 AGEUSIA 20 0.0008
823 HERPES ZOSTER 46 0.0008
824 HYPOAESTHESIA ORAL 12 0.0008
825 FOOT FRACTURE 15 0.0008
826 APHONIA 11 0.0008
827 BONE MARROW FAILURE 16 0.0008
828 VISUAL IMPAIRMENT 97 0.0008
829 NEURALGIA 19 0.0008
830 LEUKOPENIA 39 0.0008
831 SKIN DISORDER 26 0.0008
832 GLAUCOMA 15 0.0008
833 DIPLOPIA 20 0.0008
834 CHOKING 15 0.0008
835 ANAPHYLACTIC REACTION 42 0.0008
836 KNEE ARTHROPLASTY 16 0.0008
837 BLOOD PRESSURE ABNORMAL 15 0.0008
838 ILLNESS 77 0.0007
839 ADVERSE DRUG REACTION 67 0.0007
840 INFLUENZA 83 0.0007
841 HEART RATE INCREASED 73 0.0007
842 DYSPHONIA 43 0.0007
843 DYSURIA 27 0.0007
844 HYPERSOMNIA 21 0.0007
845 WHITE BLOOD CELL COUNT DECREASED 78 0.0007
846 NEPHROLITHIASIS 33 0.0007
847 TOOTHACHE 13 0.0007
848 SKIN FISSURES 14 0.0007
849 SKIN EXFOLIATION 60 0.0007
850 LIMB DISCOMFORT 22 0.0007
851 LUNG INFECTION 11 0.0007
852 THERAPY CESSATION 36 0.0007
853 ERYTHEMA 144 0.0007
854 LIMB INJURY 19 0.0007
855 PREGNANCY 14 0.0007
856 SPINAL FRACTURE 14 0.0007
857 PRURITUS 266 0.0007
858 FUNGAL INFECTION 23 0.0007
859 INTESTINAL OBSTRUCTION 26 0.0007
860 PRODUCT PRESCRIBING ISSUE 15 0.0007
861 DISEASE PROGRESSION 80 0.0007
862 HYPOACUSIS 29 0.0007
863 ABDOMINAL PAIN LOWER 17 0.0007
864 PRODUCT PRESCRIBING ERROR 16 0.0007
865 HAEMATURIA 23 0.0007
866 THIRST 12 0.0007
867 METASTASES TO BONE 11 0.0007
868 OROPHARYNGEAL PAIN 62 0.0007
869 HAEMORRHAGE 70 0.0007
870 IRRITABILITY 40 0.0007
871 CHROMATURIA 15 0.0007
872 BLOOD PRESSURE DECREASED 44 0.0007
873 MULTIPLE SCLEROSIS RELAPSE 45 0.0007
874 CONJUNCTIVITIS 12 0.0006
875 DRUG INEFFECTIVE 849 0.0006
876 DEVICE DISLOCATION 28 0.0006
877 BRONCHITIS 47 0.0006
878 PALPITATIONS 74 0.0006
879 HEPATOTOXICITY 14 0.0006
880 ANGINA PECTORIS 18 0.0006
881 PSORIASIS 82 0.0006
882 HERNIA 12 0.0006
883 VISION BLURRED 85 0.0006
884 NEEDLE ISSUE 18 0.0006
885 RASH GENERALISED 16 0.0006
886 GALLBLADDER DISORDER 11 0.0006
887 CEREBROVASCULAR ACCIDENT 104 0.0006
888 DIVERTICULITIS 17 0.0006
889 CHILLS 71 0.0006
890 INTENTIONAL PRODUCT MISUSE 53 0.0006
891 VISUAL ACUITY REDUCED 20 0.0006
892 RESTLESSNESS 22 0.0006
893 BURNING SENSATION 42 0.0006
894 PRODUCT DISPENSING ERROR 13 0.0006
895 HIP FRACTURE 19 0.0006
896 SKIN DISCOLOURATION 27 0.0006
897 THROAT IRRITATION 26 0.0006
898 RENAL DISORDER 27 0.0006
899 LOCALISED INFECTION 14 0.0006
900 VIRAL INFECTION 19 0.0006
901 ABASIA 14 0.0006
902 CHEST DISCOMFORT 58 0.0006
903 UNEVALUABLE EVENT 42 0.0006
904 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 100 0.0006
905 ARTHRITIS 43 0.0005
906 DRUG RESISTANCE 14 0.0005
907 FLUSHING 55 0.0005
908 MYOCARDIAL INFARCTION 94 0.0005
909 LYMPHADENOPATHY 19 0.0005
910 OSTEONECROSIS OF JAW 13 0.0005
911 GASTRIC DISORDER 18 0.0005
912 INJECTION SITE RASH 16 0.0005
913 EMOTIONAL DISORDER 16 0.0005
914 CARDIAC DISORDER 48 0.0005
915 FLATULENCE 29 0.0005
916 EYE PRURITUS 17 0.0005
917 MYALGIA 86 0.0005
918 FEELING ABNORMAL 119 0.0005
919 CORONARY ARTERY DISEASE 15 0.0005
920 RHINORRHOEA 32 0.0005
921 HEART RATE IRREGULAR 11 0.0005
922 INJECTION SITE MASS 18 0.0005
923 OCULAR HYPERAEMIA 23 0.0005
924 BLOOD PRESSURE INCREASED 74 0.0005
925 PRODUCT DOSE OMISSION ISSUE 142 0.0005
926 DEATH 414 0.0005
927 DRUG ABUSE 40 0.0005
928 BONE DENSITY DECREASED 15 0.0005
929 CARDIOVASCULAR DISORDER 12 0.0005
930 EMOTIONAL DISTRESS 57 0.0005
931 LACRIMATION INCREASED 14 0.0005
932 VERTIGO 28 0.0005
933 DEAFNESS 12 0.0005
934 HEART RATE DECREASED 16 0.0005
935 HEPATIC FUNCTION ABNORMAL 17 0.0005
936 HOT FLUSH 34 0.0005
937 DIABETES MELLITUS 34 0.0004
938 THERAPEUTIC RESPONSE UNEXPECTED 20 0.0004
939 THROAT TIGHTNESS 12 0.0004
940 EYE IRRITATION 25 0.0004
941 INTERSTITIAL LUNG DISEASE 21 0.0004
942 MALIGNANT NEOPLASM PROGRESSION 44 0.0004
943 THERAPEUTIC RESPONSE DECREASED 26 0.0004
944 ANAPHYLACTIC SHOCK 11 0.0004
945 EYE DISORDER 14 0.0004
946 BLOOD GLUCOSE INCREASED 80 0.0004
947 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
948 LIP SWELLING 14 0.0004
949 BLINDNESS 17 0.0004
950 NERVOUS SYSTEM DISORDER 13 0.0004
951 BONE PAIN 24 0.0004
952 NASAL CONGESTION 24 0.0004
953 MOOD ALTERED 11 0.0004
954 NEOPLASM PROGRESSION 14 0.0004
955 NERVOUSNESS 21 0.0004
956 DISEASE RECURRENCE 19 0.0004
957 LUNG NEOPLASM MALIGNANT 16 0.0004
958 ACNE 29 0.0004
959 INFLUENZA LIKE ILLNESS 31 0.0004
960 MULTIPLE SCLEROSIS 18 0.0004
961 BLOOD GLUCOSE DECREASED 18 0.0004
962 DERMATITIS ATOPIC 19 0.0004
963 PLASMA CELL MYELOMA 14 0.0004
964 CRYING 13 0.0004
965 INCORRECT DOSE ADMINISTERED 81 0.0004
966 BREAST CANCER 33 0.0004
967 COMPLETED SUICIDE 29 0.0003
968 SURGERY 20 0.0003
969 OSTEONECROSIS 11 0.0003
970 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 23 0.0003
971 DEVICE USE ERROR 11 0.0003
972 DRY SKIN 41 0.0003
973 PRODUCT DOSE OMISSION 20 0.0003
974 INJECTION SITE SWELLING 23 0.0003
975 DRUG DOSE OMISSION 47 0.0003
976 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 57 0.0003
977 ABORTION SPONTANEOUS 11 0.0003
978 NEOPLASM MALIGNANT 18 0.0003
979 DEVICE ISSUE 24 0.0003
980 INJECTION SITE ERYTHEMA 33 0.0003
981 INJECTION SITE PAIN 74 0.0002
982 DYSGEUSIA 17 0.0002
983 ACCIDENTAL EXPOSURE TO PRODUCT 21 0.0002
984 DRUG WITHDRAWAL SYNDROME 17 0.0002
985 DEVICE MALFUNCTION 13 0.0002
986 INJECTION SITE PRURITUS 11 0.0002
987 INJECTION SITE BRUISING 13 0.0002
988 NO ADVERSE EVENT 29 0.0002
989 PRODUCT STORAGE ERROR 14 0.0002
990 DRUG DEPENDENCE 22 0.0001